The human Pegivirus (HPgV, also known as GBV-C virus or hepatitis G virus) is a lymphotropic RNA-virus phylogenetically related to the Hepatitis C virus, which infects approximately 5% of the world's human population. Recently, two novel, presumably hepatotropic, pegiviruses, designated as equine Pegivirus (EPgV) and Theiler's Disease Associated Virus (TDAV), were discovered in horses with clinical and laboratory evidence of hepatic disease. To verify the occurrence of pegiviruses infection in horses from Pará State, northern Brazil, serum samples from 114 horses located in four cities (Acará, Belém, Dom Eliseu and Ananindeua) were submitted for the molecular analysis of EPgV by nested RT-PCR. The results of nucleotide sequencing and phylogenetic analysis of EPgV NS3 and NS5B genomic regions confirmed one positive sample among 114 tested samples (1/114; 0.8%). No evidence of TDAV infection was found, but despite the low prevalence and unknown clinical significance among the studied population, these results represent the first molecular detection of EPgV in horses in South America.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.actatropica.2015.08.014DOI Listing

Publication Analysis

Top Keywords

equine pegivirus
8
south america
8
hepatitis virus
8
analysis epgv
8
report equine
4
pegivirus south
4
america brazil
4
brazil human
4
human pegivirus
4
pegivirus hpgv
4

Similar Publications

Equine parvovirus-hepatitis is detected in South America, Brazil.

Transbound Emerg Dis

September 2022

Laboratório de Desenvolvimento Tecnológico em Virologia, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro, Brasil.

The equine parvovirus-hepatitis (EqPV-H), recently identified in association with serum hepatitis in horses (also known as Theiler's disease), has been so far described in horses from North America, Asia and Europe. There is no information regarding its circulation in South America. Our retrospective study (2013-2016) screened by EqPV-H nested-PCR a total of 96 Brazilian horses grouped according to previous status of infection: Known to be positive for one or more horse "hepatitis viruses" (equine hepacivirus, equine pegivirus-EPgV and Theiler's disease-associated virus) and known to be negative.

View Article and Find Full Text PDF

The First Nonmammalian Pegivirus Demonstrates Efficient Replication and High Lymphotropism.

J Virol

September 2020

Research Center of Avian Disease, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu City, Sichuan Province, China

Article Synopsis
  • Scientists found a new type of virus called goose pegivirus (GPgV) that infects geese, which is different from other pegiviruses that mostly infect mammals.
  • This virus can grow well in geese and causes some health problems, like making them lose weight and even die.
  • The study is important because it helps researchers understand how pegiviruses work and shows that not all pegiviruses are harmless like the ones seen before.
View Article and Find Full Text PDF

Equine pegiviruses cause persistent infection of bone marrow and are not associated with hepatitis.

PLoS Pathog

July 2020

Copenhagen Hepatitis C Program (CO-HEP), Department of Infectious Diseases, Hvidovre Hospital and Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.

Pegiviruses frequently cause persistent infection (as defined by >6 months), but unlike most other Flaviviridae members, no apparent clinical disease. Human pegivirus (HPgV, previously GBV-C) is detectable in 1-4% of healthy individuals and another 5-13% are seropositive. Some evidence for infection of bone marrow and spleen exists.

View Article and Find Full Text PDF

Equine parvovirus-hepatitis (EqPV-H) was first reported in a horse that died of equine serum hepatitis in the USA in 2018, and was determined having a strong association with equine serum hepatitis in the following studies. As a newly discovered virus, the genomic sequences of only seven EqPV-H strains have been reported. Considering this, an epidemiological study was performed to investigate the prevalence of EqPV-H in equines in Guangdong Province in China, and obtain genomic sequences of the field prevalent EqPV-H strains.

View Article and Find Full Text PDF
Article Synopsis
  • Hepaciviruses cause liver disease in horses, with three key viruses (NPHV, TDAV, EPgV) capable of chronic infections.
  • This study aimed to model the NS5B polymerase (an enzyme crucial for viral RNA synthesis) of equine hepaciviruses and assess how well current drugs for hepatitis C (sofosbuvir and dasabuvir) interact with them.
  • The results indicated that sofosbuvir could potentially be effective against equine pathogens, as the interactions of equine NS5B models with it were similar to those seen with HCV-NS5B, while interactions with dasabuvir showed less conservation.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!